Enalapril Maleate-Hydrochlorothiazide Tablets Articles
Biovail increases 2002 revenue guidance
27 May 2002
Generic flutamide reaches US market
20 September 2001
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
MERCK & CO POSTS 10% PR0FIT RISE
25 April 1994
Showing 1-5 of 5 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
